Cargando…
CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer
BACKGROUND: CGRRF1 is a growth suppressor and consists of a transmembrane domain and a RING-finger domain. It functions as a RING domain E3 ubiquitin ligase involved in endoplasmic reticulum-associated degradation. The expression of CGRRF1 is decreased in cancer tissues; however, the role of CGRRF1...
Autores principales: | Lee, Yu-Ju, Ho, Shiuh-Rong, Graves, Joshua D., Xiao, Yang, Huang, Shixia, Lin, Weei-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894136/ https://www.ncbi.nlm.nih.gov/pubmed/31801577 http://dx.doi.org/10.1186/s13058-019-1212-2 |
Ejemplares similares
-
Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer
por: Liu, Kang, et al.
Publicado: (2021) -
Super-enhanced MARCO variant drives triple-negative breast cancer progression
por: Lin, Weei-Chin, et al.
Publicado: (2022) -
DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors
por: Folly-Kossi, Helena, et al.
Publicado: (2023) -
14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer
por: Garan, Lidija A. Wilhelms, et al.
Publicado: (2022) -
The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System
por: Armstrong, Stephen R., et al.
Publicado: (2016)